Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingaron for Anogenital Warts
NCT05156541Phase 3Completed
- Sponsor
- SPP Pharmaclon LTD
- Start
- May 2009
- Primary completion
- Jun 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of Ingaron in anogenital warts, sponsored by SPP Pharmaclon LTD. Started May 2009; status: completed.
02
Drugs
Ingaron
03
Conditions
anogenital warts
Beyond the preview
Go deeper on NCT05156541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05156541.